Strong evidence supports the use of AI-powered portable MRI for stroke detection in multiple clinical settings, including the emergency department.

Data presented at the annual American Society of Neuroimaging meeting supports clinical value and broad utility of the portable Swoop(R) system in outpatient neurology. GUILFORD, Conn.--(BUSINESS WIRE ...

(Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain--the Swoop (R) system--today ...

A new multi-direction DWI sequence, the latest Swoop® system software, and the first advancement in Hyperfine’s Optive AI™ software, delivers clearer, higher-quality images for stroke diagnosis, ...

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine Inc. today announced results of a study of the company’s FDA-cleared portable magnetic resonance imaging (MRI) device, Swoop™, published in Nature ...

Hyperfine, Inc. ( NASDAQ:HYPR ) shareholders should be happy to see the share price up 19% in the last month. But ...

President and CEO Maria Sainz reported first quarter revenue of $2.1 million from six system sales, noting this quarter marks the end of a period where the business relied mainly on U.S. hospital ...

Portable MRI maker Hyperfine will go public via a SPAC deal and be listed on the Nasdaq, the company announced Thursday. Guilford-based Hyperfine and brain-monitoring firm Liminal Sciences were ...

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (“Hyperfine”), creator of the first U.S. Food and Drug Administration (“FDA”) cleared portable magnetic ...

The Swoop system tackles a critical challenge in health care, limited access to affordable and prompt brain imaging. More than three billion people globally are affected by brain diseases, including ...

Hyperfine Inc., a Guilford-based medical imaging technology company, has priced its underwritten public offering of 14 million shares of its Class A common stock at $1.25 per share, the company said ...